KALVISTA PHARMACEUTICALS |
USA |
Gesundheit |
US4834971032 / A2DG49 |
4XC1 (Frankfurt) / KALV (NASDAQ) |
FRA:4XC1, ETR:4XC1, 4XC1:GR, NASDAQ:KALV |
- |
https://www.kalvista.com/ |
KalVista Pharmaceuticals Inc. is a clinical-stage ..
>Volltext.. |
575.41 Mio. EUR |
479.74 Mio. EUR |
- |
-160.08 Mio. EUR |
-156.99 Mio. EUR |
-3.21 EUR |
96.01 Mio. EUR |
112.63 Mio. EUR |
-130.85 Mio. EUR |
4.88 |
- |
-36.41% |
- |
- |
- |
KALVISTA |
30.08.25 |
|